nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—narcolepsy	0.214	0.217	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0261	0.0265	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0261	0.0265	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0258	0.0262	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0258	0.0262	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0252	0.0256	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0234	0.0237	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0234	0.0237	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0226	0.0229	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HCRT—narcolepsy	0.0215	0.0218	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0212	0.0215	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0192	0.0195	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0189	0.0192	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0173	0.0176	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0173	0.0176	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0167	0.017	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—TRH—narcolepsy	0.0163	0.0165	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—TRH—narcolepsy	0.0161	0.0163	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0145	0.0148	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0142	0.0144	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0137	0.0139	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HCRTR2—narcolepsy	0.0132	0.0134	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HCRTR1—narcolepsy	0.0132	0.0134	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—P2RY11—narcolepsy	0.0127	0.0129	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0127	0.0128	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—TAC1—narcolepsy	0.0118	0.012	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—NPS—narcolepsy	0.0118	0.012	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPS—narcolepsy	0.0117	0.0118	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0117	0.0118	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HCRT—narcolepsy	0.0108	0.011	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0108	0.0109	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0106	0.0107	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0106	0.0107	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PENK—narcolepsy	0.00964	0.00978	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00944	0.00958	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00822	0.00834	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TRH—narcolepsy	0.0082	0.00832	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00782	0.00794	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00782	0.00794	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00745	0.00755	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00745	0.00755	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00719	0.0073	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HRH3—narcolepsy	0.00719	0.0073	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00711	0.00721	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00676	0.00686	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00676	0.00686	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—P2RY11—narcolepsy	0.00653	0.00663	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00636	0.00645	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HCRT—narcolepsy	0.00612	0.0062	CbGpPWpGaD
Fosaprepitant—TACR1—brainstem—narcolepsy	0.00605	0.423	CbGeAlD
Fosaprepitant—TACR1—GPCR ligand binding—NPS—narcolepsy	0.00596	0.00604	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—TAC1—narcolepsy	0.00596	0.00604	CbGpPWpGaD
Fosaprepitant—TACR1—forebrain—narcolepsy	0.00584	0.408	CbGeAlD
Fosaprepitant—TACR1—Signaling by GPCR—HCRT—narcolepsy	0.00555	0.00563	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PENK—narcolepsy	0.00545	0.00553	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PENK—narcolepsy	0.00495	0.00502	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00471	0.00478	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TRH—narcolepsy	0.00463	0.0047	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—narcolepsy	0.00442	0.00448	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TRH—narcolepsy	0.00421	0.00427	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HRH3—narcolepsy	0.00406	0.00412	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HCRTR2—narcolepsy	0.00399	0.00405	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HCRTR1—narcolepsy	0.00399	0.00405	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—P2RY11—narcolepsy	0.00386	0.00391	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HRH3—narcolepsy	0.00369	0.00374	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—narcolepsy	0.00358	0.00364	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00353	0.00358	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—TAC1—narcolepsy	0.00337	0.00342	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPS—narcolepsy	0.00337	0.00342	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HCRT—narcolepsy	0.00328	0.00333	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—TAC1—narcolepsy	0.00306	0.0031	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPS—narcolepsy	0.00306	0.0031	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PENK—narcolepsy	0.00292	0.00297	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TRH—narcolepsy	0.00249	0.00252	CbGpPWpGaD
Fosaprepitant—TACR1—brain—narcolepsy	0.00242	0.169	CbGeAlD
Fosaprepitant—TACR1—Signaling Pathways—HRH3—narcolepsy	0.00218	0.00221	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—narcolepsy	0.00203	0.00206	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—narcolepsy	0.00184	0.00187	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPS—narcolepsy	0.00181	0.00183	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAC1—narcolepsy	0.00181	0.00183	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—narcolepsy	0.00109	0.0011	CbGpPWpGaD
